Related references
Note: Only part of the references are listed.The β-Secretase BACE1 in Alzheimer's Disease
Harald Hampel et al.
BIOLOGICAL PSYCHIATRY (2021)
7-Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation
Fernanda Rodriguez-Enriquez et al.
CHEMMEDCHEM (2021)
Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis
German Plascencia-Villa et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches
Natalia F. F. Pirolla et al.
CURRENT DRUG TARGETS (2021)
Acetylcholinesterase inhibitors for the treatment of Alzheimer's disease - a patent review (2016-present)
Martina Bortolami et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2021)
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer's Disease
Benjamin Guieu et al.
MOLECULES (2021)
Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimets drugs dealing with cholinergic, amyloid and mitochondrial systems
Eugenie Nepovimova et al.
BIOORGANIC CHEMISTRY (2021)
Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases
Daniel Chavarria et al.
ANTIOXIDANTS (2021)
(±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease
Lhassane Ismaili et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease
Michele Rossi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model
Feng He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection
Qi Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters
Anna Pasieka et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer's disease
Ziyi Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
Ahmad Abu Turab Naqvi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties
Clara Herrera-Arozamena et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands
Aida Iraji et al.
BIOORGANIC CHEMISTRY (2020)
SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer’s Disease
Bo Liu et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study
Gerald Novak et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
Julia Companys-Alemany et al.
PHARMACEUTICS (2020)
Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors
Judite R. M. Coimbra et al.
BIOMOLECULES (2020)
Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor
Qi Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
F. Javier Perez-Areales et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Can We Treat Neuroinflammation in Alzheimer's Disease?
Sandra Sanchez-Sarasua et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Implementation of a functional endpoint to the zebrafish embryotoxicity test to evaluate craniofacial abnormalities
Marta Barenys et al.
TOXICOLOGY IN VITRO (2019)
Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model
Matthias Hoffmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases
Alba Espargaro et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Postsynaptic density protein 95 (PSD-95) is transported by KIF5 to dendritic regions
Ki-Seo Yoo et al.
MOLECULAR BRAIN (2019)
History and progress of hypotheses and clinical trials for Alzheimer's disease
Pei-Pei Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease
Miguel A. Maia et al.
PHARMACEUTICALS (2019)
BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease
Federica Prati et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model
Christian Grinan-Ferre et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Lipophilic Efficiency as an Important Metric in Drug Design
Ted W. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline-Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer's Disease
Zhiren Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
High-throughput assay comparison and standardization for metal chelating capacity screening: A proposal and application
Janio Sousa Santos et al.
FOOD CHEMISTRY (2017)
Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein-huprine hybrids
Francisco Javier Perez-Areales et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease
Yong Li et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments
Giovanni Bottegoni et al.
CHEMMEDCHEM (2016)
Rhein-Huprine Derivatives Reduce Cognitive Impairment, Synaptic Failure and Amyloid Pathology in AβPPswe/PS-1 Mice of Different Ages
Felipe G. Serrano et al.
CURRENT ALZHEIMER RESEARCH (2016)
Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease
Sultan Darvesh
CURRENT ALZHEIMER RESEARCH (2016)
Behaviour and cognitive changes correlated with hippocampal neuroinflammaging and neuronal markers in female SAMP8, a model of accelerated senescence
Christian Grinan-Ferre et al.
EXPERIMENTAL GERONTOLOGY (2016)
Advancements in zebrafish applications for 21st century toxicology
Gloria R. Garcia et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs
Alba Espargaro et al.
SCIENTIFIC REPORTS (2016)
Data Warrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
Thomas Sander et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Zebrafish as tools for drug discovery
Calum A. MacRae et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Computational Methods in the Discovery and Design of BACE-1 Inhibitors
P. Kacker et al.
CURRENT MEDICINAL CHEMISTRY (2015)
The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-β Species in Alzheimer's Disease
Masha G. Savelieff et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
Thioflavin-S Staining of Bacterial Inclusion Bodies for the Fast, Simple, and Inexpensive Screening of Amyloid Aggregation Inhibitors
S. Pouplana et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies
Ornella Di Pietro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Oxidative Stress in Alzheimer's Disease: Are We Connecting the Dots?
Michela Rosini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents
Elisabet Viayna et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's disease
Andrea Tarozzi et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2014)
Neprilysin and Aβ clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer's disease
Marcus O. W. Grimm et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease
John E. Morley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
The SAMP8 Mouse: A Model to Develop Therapeutic Interventions for Alzheimers Disease
John E. Morley et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
ZINC: A Free Tool to Discover Chemistry for Biology
John J. Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases
Caries Galdeano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Fragment screening to predict druggability (ligandability) and lead discovery success
Fredrik N. B. Edfeldt et al.
DRUG DISCOVERY TODAY (2011)
An Overview of APP Processing Enzymes and Products
Vivian W. Chow et al.
NEUROMOLECULAR MEDICINE (2010)
Improved side-chain torsion potentials for the Amber ff99SB protein force field
Kresten Lindorff-Larsen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Pyrano[3,2-c]quinoline-6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds
Pelayo Camps et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Senescence-Accelerated Mouse (SAM) with Special References to Neurodegeneration Models, SAMP8 and SAMP10 Mice
Toshio Takeda
NEUROCHEMICAL RESEARCH (2009)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice
Lisa McConlogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Molecular anatomy of a trafficking organelle
Shigeo Takamori et al.
CELL (2006)
Comparison of multiple amber force fields and development of improved protein backbone parameters
Viktor Hornak et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Zebrafish as a model vertebrate for investigating chemical toxicity
AJ Hill et al.
TOXICOLOGICAL SCIENCES (2005)
The chemistry behind antioxidant capacity assays
DJ Huang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells
M Pickhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility
KA Dehring et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids
MDM Alcalá et al.
NEUROPHARMACOLOGY (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
High throughput artificial membrane permeability assay for blood-brain barrier
L Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
New tacrine-huperzine A hybrids (huprines):: Highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease
P Camps et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
